Nektar Therapeutics(DE:ITH0)
€34.94+1.34 (+3.99%)
DE:ITH0
Nektar Therapeutics earnings date
€34.94
At close:+1.34 (+3.99%)
Nektar Therapeutics (ITH0) Q3 2026 Earnings Report
1 Followers
DE:ITH0 Q3 2026 EPS Results
- Actual EPS
- -EUR 1.47
- Consensus EPS
- -EUR 1.87
- Beat/Miss
- Beat by +EUR 0.40
- One Year Ago EPS
- -EUR 1.69
DE:ITH0 Q3 2026 Revenue Results
- Actual Revenue
- EUR 8.48M
- Expected Revenue
- EUR 9.29M
- Beat/Miss
- Missed by -EUR 802.69K
- YoY Revenue Growth
- -20.39%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/12/2026
- Time
- After Close
- Conference Call
- Thursday, November 12, 2026
DE:ITH0 Upcoming Earnings
Nektar Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
DE:ITH0 Q3 2026 Earnings Call
0:00 / 0:00
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:ITH0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -2.49- | -1.61 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -1.87-1.47 | -1.69 | 12.83% (+0.22) | |
| Aug 13, 2026 | 2026 (Q2) | -1.78-1.11 | -2.67 | 58.31% (+1.55) | |
| May 07, 2026 | 2026 (Q1) | -1.43-1.65 | -3.25 | 49.44% (+1.61) | |
| Mar 12, 2026 | 2025 (Q4) | -2.24-1.61 | 0.41 | -495.56% (-2.02) | |
| Nov 06, 2025 | 2025 (Q3) | -2.43-1.69 | -2.44 | 30.74% (+0.75) | |
| Aug 07, 2025 | 2025 (Q2) | -2.74-2.67 | -3.39 | 21.33% (+0.72) | |
| May 08, 2025 | 2025 (Q1) | -2.32-3.25 | -2.58 | -26.32% (-0.68) | |
| Mar 12, 2025 | 2024 (Q4) | -1.840.41 | -2.98 | 113.64% (+3.39) | |
| Nov 07, 2024 | 2024 (Q3) | -2.70-2.44 | -3.25 | 25.00% (+0.81) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
